Presentation of Dr. Ingo Potrykus July 21 in Providence

PROVIDENCE, RI, -- The American Society of Plant Biologists (ASPB) will present the ASPB Leadership in Science Public Service Award to Dr. Ingo Potrykus July 21, 2001 at the ASPB annual meeting in Providence.

The award recognizes Dr. Potrykus' outstanding contributions to science and humanity through his research. Dr. Potrykus' research contributes to food security in developing nations by developing and applying genetic engineering technology to crop plants such as rice, wheat, sorghum and cassava. Dr. Potrykus addresses problems difficult to solve with traditional techniques in the areas of plant disease and pest resistance, improved food quality, improved yield, improved exploitation of natural resources and improved biosafety.

Dr. Potrykus has genetically modified rice (Golden Rice) to have higher levels of beta carotene that could address Vitamin A deficiencies of people in developing nations where rice is the staple of their daily diets. Beta carotene converts to Vitamin A after human consumption.

Dr. Potrykus' tremendous contributions to plant science and society have been recognized in science journals and in the general media. As Time magazine noted in its cover story on Swiss Professor Potrykus and on Golden Rice, "this rice could save a million kids a yearbut protesters believe such genetically modified foods are bad for us and our planet" Golden Rice could potentially save nearly 500,000 children a year from being stricken blind from Vitamin A deficiencies in their diet.


Contact: Brian Hyps
American Society of Plant Biologists

Page: 1

Related biology news :

1. Neurons Control Brain Immunity: Neurotrophins As Regulators Of Antigen-Presentation In Microglial Cells
2. Summary Of USGS Presentations And Activities, AAAS, 1998
3. Quadrennial joint annual meetings of American Society of Plant Biologists and Canadian Society of Plant Physiologists in Providence July 21-25 will present latest advances in plant science

Post Your Comments:

(Date:8/21/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application for ... Approval of this IND allows Sentien to initiate a Phase 1/2 study with ...
(Date:8/12/2020)... Mich. (PRWEB) , ... August 11, 2020 , ... ... R&D subsidiary based in Princeton, NJ, have entered into license agreements with Housey ... and development. Both Roche and J&J have annual Research and Development spending ...
(Date:8/5/2020)... ... 05, 2020 , ... Regenative Labs has received approval from the Centers for ... them the first Wharton’s jelly allografts to be assigned a Q code and be ... the first Wharton’s jelly allograft product to be recognized as a 361 HCT/P by ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 2020 , ... Bode Technology, a leading provider ... through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical testing ... provides a turnkey solution that includes a comprehensive collection and virus-management program for ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, ... the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. ... of Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor ...
(Date:7/1/2020)... (PRWEB) , ... June 29, 2020 , ... ... year to date growth of 40% in 2020, despite many obstacles created as ... MedShift aims to increase revenue for its partnered medical practices and medical manufacturers ...
(Date:6/28/2020)... ... 2020 , ... The Indoor Lab, a leading provider of sensor solutions for ... types to ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ technology using ... will provide a health performance index system that scores all aspects of compliance similar ...
Breaking Biology Technology:
Cached News: